Individual security in academic discourse

by Popović-Mančević Marija, Ružić Maja
Published 2017-01-01

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C

by Preveden Tomislav, Ružić Maja, Pete Maria
Published 2017-01-01

Chronic fatigue syndrome

by Brkić Snežana, Tomić Slavica, Ružić Maja, Marić Daniela
Published 2011-01-01

Exercise induced rhabdomyolysis

by Ružič Maja, Fabri Milotka, Pobor Marta, Jovelić Aleksandra, Lukač Damir
Published 2009-01-01

The occurrence of liver steatosis in patients with chronic hepatitis C - the experience of the Clinical Center of Vojvodina

by Preveden Tomislav, Ružić Maja, Kovačević Nadica, Pete Maria, Fabri Milotka
Published 2018-01-01

Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with Pegylated interferon alfa-2a and ribavirin

by Fabri Milotka, Ružić Maja, Lendak Dajana, Preveden Tomislav, Fabri Izabela, Petrić Vedrana
Published 2013-01-01

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy

by Ružić Maja, Fabri Milotka, Preveden Tomislav, Bačulov Katarina, Pete Maria, Stojšin Anja
Published 2018-01-01

Visceral leishmaniasis as a cause of postpartum pyrexia — case report

by Milosevic Stevan, Bogavac Mirjana, Malenkovic Goran, Fabri Milotka, Ruzic Maja, Dugandzija Tihomir
Published 2013-04-01

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study

by Ružić Maja, Fabri Milotka, Stojanoska Medić Milica, Bajkin Ivana, Turkulov Vesna, Abenavoli Ludovico
Published 2017-01-01

The costs of urinary tract infection therapy with implementation of pharmacoeconomic guidelines at the clinic for infectious diseases of the Clinical center of Vojvodina

by Stefan-Mikić Sandra, Sević Siniša, Doder Radoslava, Cvjetković Dejan, Jovanović Nataša, Ružić Maja
Published 2012-01-01

Treatment of chronic hepatitis C among injecting drug users: A 5-year follow-up

by Ruzić Maja, Fabri Milotka, Preveden Tomislav, Kiralj Katarina, Mikić Stefan Sandra, Vukadinov Tatjana
Published 2013-01-01

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users

by Ružić Maja, Fabri Milotka, Klašnja Biljana, Pobor Marta, Švarc Daniela, Jovelić Aleksandra, Fabri Izabela
Published 2010-01-01

Protection of health workers employed in a tertiary health institution from hepatitis B virus infection

by Bogdanović-Vasić Slobodanka, Stojčević-Maletić Jelena, Brestovački-Svitlica Branislava, Mićunović Sandra, Knežević Violeta, Antonić Roland, Ružić Maja
Published 2020-01-01